About C2Dx
C2Dx is a company based in Schoolcraft (United States) founded in 2018 by Kevin McLeod. C2Dx has completed 1 acquisition, including Hemostatix. C2Dx offers products and services including Shaw Scalpel, STIC Pressure Monitor, Biodesign Otologic Repair, Biodesign Sinonasal Repair, and T/Pump. C2Dx operates in a competitive market with competitors including Endoron Medical, Bolder Surgical, revmedica, Reach Surgical and Amplify Surgical, among others.
- Headquarter Schoolcraft, United States
- Founders Kevin McLeod
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name C2dx, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of C2Dx
C2Dx offers a comprehensive portfolio of products and services, including Shaw Scalpel, STIC Pressure Monitor, Biodesign Otologic Repair, Biodesign Sinonasal Repair, and T/Pump.
Uses thermal energy to seal blood vessels during precise surgeries
Aids in diagnosing compartment syndrome accurately and timely
Supports natural healing in otologic procedures like tympanoplasty
Facilitates healing for nasal septal perforations and repairs
Provides localized temperature therapy for pain and orthopedic conditions
Funding Insights of C2Dx
Detailed funding history for C2Dx
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by C2Dx
C2Dx has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Hemostatix.
Investment portfolio details for C2Dx
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Precision thermal scalpels for surgical vessel sealing are developed.
|
Locked | Locked | 2006 | Locked |
Complete acquisition details for C2Dx
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - C2Dx
Detailed financials for C2Dx
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
C2dx Comparisons
Peer comparison for C2Dx
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of C2Dx
C2Dx operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Endoron Medical, Bolder Surgical, revmedica, Reach Surgical and Amplify Surgical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Endovascular fixation devices for cardiovascular stent grafts are manufactured.
|
|
| Locked | Locked | Locked |
Developer of electrosurgical device for pediatric patients
|
|
| Locked | Locked | Locked |
Laparoscopic surgical staplers are developed for minimally invasive procedures.
|
|
| Locked | Locked | Locked |
Surgical staplers and energy devices are manufactured and distributed globally.
|
|
| Locked | Locked | Locked |
Provider of various surgical solutions
|
Detailed competitors of C2Dx
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on C2dx
Complete news archive for C2Dx
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about C2Dx
C2Dx was founded in 2018.
C2Dx is headquartered in Schoolcraft, United States. It is registered at Schoolcraft, Michigan, United States.
Kevin McLeod is the current CEO of C2Dx. They have also founded this company.
C2Dx provider of medical products and related services, focusing on providing healthcare solutions, and traditional medical devices. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets. It continues to evolve, meeting industry challenges with strategic approaches.
C2Dx's top competitors include Bolder Surgical, revmedica and Amplify Surgical.
C2Dx offers Shaw Scalpel, STIC Pressure Monitor, Biodesign Otologic Repair, Biodesign Sinonasal Repair, and T/Pump.
C2Dx has made 1 acquisition, including Hemostatix.